Hongwei Wu

4.1k total citations · 1 hit paper
76 papers, 3.1k citations indexed

About

Hongwei Wu is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Hongwei Wu has authored 76 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Biomedical Engineering. Recurrent topics in Hongwei Wu's work include TiO2 Photocatalysis and Solar Cells (8 papers), Neuroblastoma Research and Treatments (7 papers) and 3D Printing in Biomedical Research (7 papers). Hongwei Wu is often cited by papers focused on TiO2 Photocatalysis and Solar Cells (8 papers), Neuroblastoma Research and Treatments (7 papers) and 3D Printing in Biomedical Research (7 papers). Hongwei Wu collaborates with scholars based in China, United States and Italy. Hongwei Wu's co-authors include Robert C. Seeger, Leonid S. Metelitsa, Dechun Zou, Shaocong Hou, Zhibin Lv, Dan Wang, Yongping Fu, Zengze Chu, Shahab Asgharzadeh and Hongwei Ouyang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Hongwei Wu

72 papers receiving 3.1k citations

Hit Papers

High-efficient engineerin... 2022 2026 2023 2024 2022 40 80 120

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hongwei Wu 820 630 603 592 385 76 3.1k
Xiuling Xu 211 0.3× 186 0.3× 1.0k 1.7× 1.3k 2.2× 332 0.9× 96 3.6k
Jingjing Ye 233 0.3× 351 0.6× 662 1.1× 1.2k 2.1× 173 0.4× 128 2.9k
Wenting Zheng 285 0.3× 419 0.7× 461 0.8× 689 1.2× 228 0.6× 65 2.4k
Liqun Yang 244 0.3× 738 1.2× 633 1.0× 1.4k 2.3× 376 1.0× 151 4.1k
A. Ian Cassady 359 0.4× 569 0.9× 589 1.0× 1.3k 2.3× 150 0.4× 50 2.8k
Yourong Duan 393 0.5× 412 0.7× 1.6k 2.7× 1.5k 2.6× 174 0.5× 130 3.8k
Yuting Deng 336 0.4× 170 0.3× 559 0.9× 308 0.5× 524 1.4× 76 2.1k
Ji‐Won Jung 262 0.3× 425 0.7× 192 0.3× 978 1.7× 196 0.5× 74 2.5k
Nan Zhao 116 0.1× 456 0.7× 730 1.2× 1.0k 1.7× 238 0.6× 108 3.3k

Countries citing papers authored by Hongwei Wu

Since Specialization
Citations

This map shows the geographic impact of Hongwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Wu more than expected).

Fields of papers citing papers by Hongwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Wu. The network helps show where Hongwei Wu may publish in the future.

Co-authorship network of co-authors of Hongwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Wu. A scholar is included among the top collaborators of Hongwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Wu. Hongwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Si, et al.. (2025). Modulatory Effects of Jujuboside A on Amino Acid Neurotransmitter Profiles in Tic Disorder. Brain and Behavior. 15(11). e71041–e71041.
2.
Zhang, Qiuyun, Hongwei Wu, Nian Xu, et al.. (2025). Facile fabrication of heteropolyacid/bimetallic Bi/Ce-MOFs hybrid catalyst for sustainable biodiesel synthesis. BMC Chemistry. 19(1). 294–294.
3.
Ma, Yuanzhu, Tao Lei, Hongwei Wu, et al.. (2024). An in situ forming cartilage matrix mimetic hydrogel scavenges ROS and ameliorates osteoarthritis after superficial cartilage injury. Acta Biomaterialia. 187. 82–97. 12 indexed citations
5.
Wu, Hongwei, et al.. (2024). Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering. Cell Transplantation. 33. 4241334589–4241334589. 16 indexed citations
6.
He, Feng, et al.. (2024). Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances. Frontiers in Pharmacology. 15. 1488036–1488036. 5 indexed citations
7.
Wu, Hongwei, et al.. (2023). The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis. Stem Cells International. 2023. 1–11. 9 indexed citations
8.
Liu, Wei, et al.. (2023). Noggin Protein can Induce the Differentiation of Rat Bone Marrow Mesenchymal Stem Cells to Neurons and Repair Spinal Cord Injury. Discovery Medicine. 35(179). 956–956. 2 indexed citations
9.
Xu, Yan, et al.. (2022). Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticles on Osteosarcoma. Frontiers in Bioengineering and Biotechnology. 10. 897641–897641. 19 indexed citations
10.
Yao, Xudong, Yuanzhu Ma, Wenyan Zhou, et al.. (2021). In‐cytoplasm mitochondrial transplantation for mesenchymal stem cells engineering and tissue regeneration. Bioengineering & Translational Medicine. 7(1). e10250–e10250. 33 indexed citations
11.
Wu, Hongwei, Tingting Guo, Jie Bu, et al.. (2021). Surface coating prolongs the degradation and maintains the mechanical strength of surgical suture in vivo. Colloids and Surfaces B Biointerfaces. 209(Pt 1). 112214–112214. 21 indexed citations
12.
Wu, Hongwei, et al.. (2021). Efficient and Consistent Orthotopic Osteosarcoma Model by Cell Sheet Transplantation in the Nude Mice for Drug Testing. Frontiers in Bioengineering and Biotechnology. 9. 690409–690409. 5 indexed citations
13.
Zobel, Michael J., Hongwei Wu, Jianping Sun, et al.. (2020). Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice. Journal for ImmunoTherapy of Cancer. 8(2). e001560–e001560. 13 indexed citations
14.
Jackson, Jeremy R., Grace E. Asuelime, Hongwei Wu, et al.. (2018). Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma. Clinical Cancer Research. 25(1). 325–333. 48 indexed citations
15.
Shen, Feng, et al.. (2017). Analysis of value of laparoscopic hepatectomy in the treatment of hepatic hemangioma. 33(8). 729–733. 1 indexed citations
16.
Chen, Daiqin, Casey A. Dougherty, Dongzhi Yang, Hongwei Wu, & Hao Hong. (2016). Radioactive Nanomaterials for Multimodality Imaging. Tomography. 2(1). 3–16. 20 indexed citations
17.
Wu, Hongwei, et al.. (2016). Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease. Neuroscience Letters. 629. 116–118. 6 indexed citations
18.
Wu, Hongwei. (2008). Arthroscopic treatment for tibial plateau fractures. 2 indexed citations
19.
Metelitsa, Leonid S., Hongwei Wu, Hong Wang, et al.. (2004). Natural Killer T Cells Infiltrate Neuroblastomas Expressing the Chemokine CCL2. The Journal of Experimental Medicine. 199(9). 1213–1221. 207 indexed citations
20.
Metelitsa, Leonid S., Olga V. Naidenko, Anita Kant, et al.. (2001). Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells. The Journal of Immunology. 167(6). 3114–3122. 293 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026